Voltar
Revisão Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology – ASBAI

2022; Elsevier BV; Volume: 15; Issue: 10 Linguagem: Inglês

10.1016/j.waojou.2022.100697

ISSN

1939-4551

Autores

Fernando Monteiro Aarestrup, Ernesto Akio Taketomi, Clóvis Eduardo Santos Galvão, Elaine Gagete, Anna Caroline Nóbrega Machado Arruda, Gil Bardini Alves, Geórgia Véras de Araújo Gueiros Lira, Marcos Reis Gonçalves, Mariana Graça Couto Miziara, Sidney Souteban Maranhão Casado, Simone Valladão Curi, Veridiana Aun Rufino Pereira, Valéria Sales, Dirceu Solé, Norma de Paula Motta Rubini, Emanuel Sarinho,

Tópico(s)

Food Allergy and Anaphylaxis Research

Resumo

Allergen Immunotherapy (AIT) represents one of the pillars in the treatment of allergic diseases. AIT is the only therapeutic strategy with curative potential, promoting the reduction of drug use and long-term symptom control even after the end of the treatment. The European Academy of Allergy, Asthma and Immunology (EAACI) guidelines, position papers of World Allergy Organization (WAO), and the US Practice Parameters are the leading official documents that set scientific standard for the use of AIT in the world. The use of AIT in Brazil has specific regional conditions due to the pattern of allergen sensitization, as well as genetic, socioeconomic, and cultural characteristics, climate conditions, and the availability of allergenic extracts. The most prevalent house dust mites are

Referência(s)